Affymetrix pioneered the microarray technology used to publish more than 21,000 studies, many of which have made significant strides in understanding the relationship between genes and disease. Today the company provides a wide range of innovative genomic analysis tools to the world’s top pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and nonprofit research institutes.
Our products include complete microarray systems for expression and genotyping studies, quantitative assays for multi- to single-gene analysis, and premium molecular biology reagents. Whether you’re interrogating entire genomes or individual molecules, RNA or DNA, 100,000 or 10 samples, Affymetrix offers solutions for every step in the genetic discovery, qualification, and validation continuum.
Affymetrix is headquartered in Santa Clara, California and serves life scientists globally with offices in the United Kingdom, Japan, China, and Singapore.